The journal retracts the article titled “Metformin and Breast Cancer: Where Are We Now?” [], cited above.
Following publication, concerns were brought to the attention of the Editorial Office regarding the unauthorized use of propriety data presented within this article [].
Adhering to our complaints procedure, the Editorial Office and Editorial Board conducted an investigation that confirmed that appropriate permission to publish the underlying data presented in this article had not been obtained. As retroactive permission could not be acquired, the Editorial Board has decided to retract this article as per MDPI’s retraction policy (https://www.mdpi.com/ethics#_bookmark30).
This retraction was approved by the Editor-in-Chief of the International Journal of Molecular Sciences.
The authors disagreed with this decision.
Reference
- Cejuela, M.; Martin-Castillo, B.; Menendez, J.A.; Pernas, S. RETRACTED: Metformin and Breast Cancer: Where Are We Now? Int. J. Mol. Sci. 2022, 23, 2705. [Google Scholar] [CrossRef] [PubMed]
Disclaimer/Publisher’s Note: The statements, opinions and data contained in all publications are solely those of the individual author(s) and contributor(s) and not of MDPI and/or the editor(s). MDPI and/or the editor(s) disclaim responsibility for any injury to people or property resulting from any ideas, methods, instructions or products referred to in the content. |
© 2025 by the authors. Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).